Publication | Open Access

New cholinesterase inhibitors for Alzheimer’s disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives

Molecular PharmacologyMedicinal ChemistryAlzheimer's DiseaseBiochemistryMedicineNatural SciencesPharmacologyRational Drug DesignPharmacological AgentNew Cholinesterase InhibitorsDrug DevelopmentMolecular DockingDrug DiscoveryAzepanone Derivatives